Last reviewed · How we verify
Skin and Skin Structure Anaerobic Infection
Approved treatments
- Cleocin T · Pfizer
Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death. - Cleocin · Generic (originally Upjohn/Pfizer)
Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Skin and Skin Structure Anaerobic Infection patent landscape — cliff calendar, originator estates, attackable patents
- Skin and Skin Structure Anaerobic Infection treatment landscape brief
- Skin and Skin Structure Anaerobic Infection treatment updates RSS
Frequently asked questions about Skin and Skin Structure Anaerobic Infection
What drugs treat Skin and Skin Structure Anaerobic Infection?
Tracked treatments include Cleocin T, Cleocin.
What is the treatment for Skin and Skin Structure Anaerobic Infection?
Standard treatment for Skin and Skin Structure Anaerobic Infection includes Cleocin T, Cleocin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Skin and Skin Structure Anaerobic Infection patent cliff · Skin and Skin Structure Anaerobic Infection CI report
- Treatment: Cleocin T · Pfizer
- Treatment: Cleocin · Generic (originally Upjohn/Pfizer)
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing